Ubeyt Inan Umit, MD (Ayfon, Turkey), Tuncay Kusbeci, MD (Afyon, Turkey), Berkant Kaderli (Bursa, Turkey), Remzi Avci, MD (Bursa, Turkey), Umit Kaplan, MD (Afyon, Turkey), Faruk Ozturk, MD (Turkey) PURPOSE: Intravitreal bevacizumab, a recombinant humanized monoclonal antibody directed against VEGF, has been increasingly used for treatment of age-related macular degeneration, PDR and macular edema due to retinal vein occlusions. We reported...

Read More